Preparation of wogonoside polycaprolactone-polyethylene glycol micelles delivered by adipose stem cells

doi:10.12307/2022.780

Abstract

Abstract: BACKGROUND: Wogonoside has been proven to have anti-inflammatory, neuroprotective and other pharmacological activities. Wogonoside is difficult to dissolve in water and has a short half-life. In an organic solvent, wogonoside may bring patients with serious adverse reactions. Polycaprolactone-polyethylene glycol can combine highly hydrophobic drugs and achieve sustained release, but cannot accurately target the lesion. Micelles, because of their small size, can penetrate cell membranes.
OBJECTIVE: To prepare wogonoside polycaprolactone-polyethylene glycol micelles and adipose stem cells as a carrier to deliver wogonoside polycaprolactone-polyethylene glycol micelles so as to overcome the insolubility and short half-life of wogonoside and enable the drug to target the damage site.
METHODS: Wogonoside polycaprolactone-polyethylene glycol micelles were prepared by dialysis method and characterized. Encapsulation rate, drug loading and in vitro drug release rate were detected. SD rat adipose stem cells were prepared by collagenase digestion. The expression of CD90, CD44, and CD45 was detected by flow cytometry, immunohistochemistry, and immunofluorescence. After 14 days of adipocytes induction, oil red O staining was performed. CCK8 assay was used to detect cytotoxicity of wogonoside polycaprolactone-polyethylene glycol micelles to adipose stem cells. The micelles of coumarin 6 and wogonoside were co-incubated with adipose stem cells for cell localization.
RESULTS AND CONCLUSION: (1) The wogonoside polycaprolactone-polyethylene glycol micelles had a mean particle size of (26.7±0.4) nm, a Zeta potential of (-33.2±0.3) mV, and a relatively uniform shape of round ball. (2) The encapsulation rate of wogonoside polycaprolactone-polyethylene glycol micelles was (90.2±2.04)% and the drug loading was (9.18±0.31)%. (3) The cumulative release rate of free wogonoside was 98% for 24 hours, and that of wogonoside polycaprolactone-polyethylene glycol micelles was 87% for 96 hours. (4) Flow cytometry, immunohistochemistry, and immunofluorescence showed that CD90 and CD44 were highly expressed, while CD45 was almost not. Oil red O staining showed red droplets after lipid induction. (5) CCK8 assay showed that the micellar mass concentration in the range of 10-200 mg/L had no effect on cells. (6) Confocal laser confocal results showed that coumarin 6 and wogonoside polycaprolactone-polyethylene glycol micelles could enter the mitochondria of adipose stem cells. (7) The results showed that the wogonoside polycaprolactone-polyethylene glycol micelles could enter adipose stem cells, and adipose stem cells could carry wogonoside polycaprolactone-polyethylene glycol micelles. wogonoside; polycaprolactone; polyethylene glycol; micelles; characterization; in vitro release; adipose stem cells

Key words: wogonoside, polycaprolactone, polyethylene glycol, micelles, characterization, in vitro release, adipose stem cells

CLC Number:

Wang Xiao, Liu Qing, Hu Yaorui, Gu Chengxu, Guo Qixuan, Zhu Yonglin, Zhang Luping. Preparation of wogonoside polycaprolactone-polyethylene glycol micelles delivered by adipose stem cells[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(31): 4996-5001.

Figures/Tables 9

References

[1] WANG C, XU T, LACHANCE BB, et al. Critical roles of sphingosine kinase 1 in the regulation of neuroinflammation and neuronal injury after spinal cord injury. J Neuroinflammation. 2021;18(1):50.
[2] ZHU Y, ZHU H, WANG Z, et al. Wogonoside alleviates inflammation induced by traumatic spinal cord injury by suppressing NF-κB and NLRP3 inflammasome activation. Exp Ther Med. 2017;14(4):3304-3308.
[3] 陆祥,蒋成君.黄酮类化合物共晶研究进展[J].医药导报,2019, 38(7):921-926.
[4] 刘伟成,任艳群,许桂顺.几种常见有机溶剂的主要性质[J].化工设计通讯,2016,42(7):13.
[5] YANG JG, ZHANG J, CHEN XJ, et al. Stable Loading and Delivery of Icaritin Using PEG-PCL Micelles for Effective Treatment of Oral Squamous Cell Carcinoma. Curr Drug Deliv. 2021;18(7):975-983.
[6] DENG H, DONG A, SONG J, et al. Injectable thermosensitive hydrogel systems based on functional PEG/PCL block polymer for local drug delivery. J Control Release. 2019;297:60-70.
[7] ALAMI-MILANI M, ZAKERI-MILANI P, VALIZADEH H, et al. PLA-PCL-PEG-PCL-PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation. Pharm Dev Technol. 2020;25(6):704-719.
[8] WANG F, XU Y, LV C, et al. Enhanced wound healing activity of PEG/PCL copolymer combined with bioactive nanoparticles in wound care after anorectal surgery: Via bio-inspired methodology. J Photochem Photobiol B. 2018;187:54-60.
[9] REZAIE P, KHOEI S, KHOEE S, et al. Evaluation of combined effect of hyperthermia and ionizing radiation on cytotoxic damages induced by IUdR-loaded PCL-PEG-coated magnetic nanoparticles in spheroid culture of U87MG glioblastoma cell line. Int J Radiat Biol. 2018;94(11):1027-1037.
[10] KAMRANI SME, HADIZADEH F. A coarse-grain MD (molecular dynamic) simulation of PCL-PEG and PLA-PEG aggregation as a computational model for prediction of the drug-loading efficacy of doxorubicin. J Biomol Struct Dyn. 2019;37(16):4215-4221.
[11] BATRAKOVA EV, GENDELMAN HE, KABANOV AV. Cell-mediated drug delivery. Expert Opin Drug Deliv. 2011;8(4):415-433.
[12] JAVED S, ALSHEHRI S, SHOAIB A, et al. Chronicles of Nanoerythrosomes: An Erythrocyte-Based Biomimetic Smart Drug Delivery System as a Therapeutic and Diagnostic Tool in Cancer Therapy. Pharmaceutics. 2021;13(3):368.
[13] WANG X, ZHAO X, HE Z. Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy. Oncol Lett. 2021;21(4):238.
[14] VISHNEVSKIY DA, GARANINA AS, CHERNYSHEVA AA, et al. Neutrophil and Nanoparticles Delivery to Tumor: Is It Going to Carry That Weight? Adv Healthc Mater. 2021;10(9):e2002071.
[15] SU Y, ZHANG T, HUANG T, et al. Current advances and challenges of mesenchymal stem cells-based drug delivery system and their improvements. Int J Pharm. 2021;600:120477.
[16] HUANG Q, ZOU Y, ARNO MC, et al. Hydrogel scaffolds for differentiation of adipose-derived stem cells. Chem Soc Rev. 2017;46(20):6255-6275.
[17] DING DC, SHYU WC, LIN SZ. Mesenchymal stem cells. Cell Transplant. 2011; 20(1):5-14.
[18] TRIPODO G, CHLAPANIDAS T, PERTEGHELLA S, et al. Mesenchymal stromal cells loading curcumin-INVITE-micelles: a drug delivery system for neurodegenerative diseases. Colloids Surf B Biointerfaces. 2015;125:300-308.
[19] KUMAR S, PANDEY AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal. 2013;2013:162750.
[20] ZHAO J, LUO D, ZHANG Z, et al. Celastrol-loaded PEG-PCL nanomicelles ameliorate inflammation, lipid accumulation, insulin resistance and gastrointestinal injury in diet-induced obese mice. J Control Release. 2019;310:188-197.
[21] LIU H, DENG S, HAN L, et al. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Colloids Surf B Biointerfaces. 2022;209(Pt 1):112163.
[22] GAO P, ZOU D, ZHAO A, et al. Design and Optimization of the Circulatory Cell-Driven Drug Delivery Platform. Stem Cells Int. 2021;2021:8502021.
[23] YOKOYAMA R, II M, MASUDA M, et al. Cardiac Regeneration by Statin-Polymer Nanoparticle-Loaded Adipose-Derived Stem Cell Therapy in Myocardial Infarction. Stem Cells Transl Med. 2019;8(10):1055-1067.
[24] 李玉秋,焦玉祥,刘锐,等.脂肪干细胞的分离培养、分化及其应用[J].沈阳医学院学报,2019,21(6):559-564.
[25] BOURIN P, BUNNELL BA, CASTEILLA L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15(6):641-648.
[26] CHIU TL, BASKARAN R, TSAI ST, et al. Intracerebral transplantation of autologous adipose-derived stem cells for chronic ischemic stroke: A phase I study. J Tissue Eng Regen Med. 2022;16(1):3-13.